ADJUTEC PHARMA AS: årsregnskap 2021 vs 2020
Grew 926% on revenue, weaker earnings, fresh owner capital
approved 2022-05-23; registry 2022-06-15; journal 2022 435242
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for ADJUTEC PHARMA AS. Revenue 612 NOK → 6 277 NOK (+925.7%). Net result -747.3k NOK → -3.52m NOK. Equity 1.28m NOK → 32.76m NOK.
On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened.
Also worth watching: headcount (årsverk) changed. All figures are taken from the published annual accounts for ADJUTEC PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 612 NOK to 6 277 NOK (+925.7% YoY). Calculated
-
↑
Equity strengthened
Book equity 1.28m NOK → 32.76m NOK (equity ratio 82.9% → 99.3%). Calculated
-
↑
Cash rose
Bank deposits 1.52m NOK → 23.85m NOK (+1469.8% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 2.02m NOK → 37.02m NOK (+35.00m NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -746.8k NOK → -5.22m NOK (op. margin -122032.0% → -83090.0%). Calculated
-
↓
Net result weakened
Net result -747.3k NOK → -3.52m NOK (net margin -122101.5% → -56013.5%). Calculated
Things to notice
-
·
Headcount (årsverk) changed
Reported FTEs 0 → 1. Reported fact